↓ Skip to main content

American Association for Cancer Research

Article Metrics

Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers

Overview of attention for article published in Molecular Cancer Therapeutics, September 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#29 of 3,477)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
178 tweeters

Readers on

mendeley
5 Mendeley
Title
Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers
Published in
Molecular Cancer Therapeutics, September 2021
DOI 10.1158/1535-7163.mct-21-0329
Pubmed ID
Authors

Jacob J. Adashek, Aakash P. Desai, Alexander Y. Andreev-Drakhlin, Jason Roszik, Gilbert J. Cote, Vivek Subbiah

Twitter Demographics

The data shown below were collected from the profiles of 178 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 20%
Other 1 20%
Student > Master 1 20%
Unknown 2 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 1 20%
Chemistry 1 20%
Medicine and Dentistry 1 20%
Unknown 2 40%

Attention Score in Context

This research output has an Altmetric Attention Score of 101. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 January 2022.
All research outputs
#289,546
of 20,144,701 outputs
Outputs from Molecular Cancer Therapeutics
#29
of 3,477 outputs
Outputs of similar age
#7,646
of 339,833 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#1
of 60 outputs
Altmetric has tracked 20,144,701 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,477 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 339,833 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.